Dr Hao-Ying Li has long-term academic and industrial experiences in the R&D of all types of inhaled dosage forms, now work in KCL on the Wellcome LEAP project to manufacture mRNAs and develop their inhalable formulations for respiratory delivery. Dr Li has expertise in inhalation drug delivery as well as in chemistry and materials, with leading roles in a number of projects and >100 publications.
